175203-58-4 Usage
Uses
Used in Organic Synthesis:
4-(2-PHENYLETH-1-YNYL)THIOPHENE-2-CARBALDEHYDE is used as a building block in organic synthesis for the preparation of a variety of functionalized molecules. Its reactivity and structural features contribute to the creation of complex organic compounds with potential applications in different fields.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 4-(2-PHENYLETH-1-YNYL)THIOPHENE-2-CARBALDEHYDE is utilized as an intermediate for the synthesis of drugs. Its unique structure allows for the development of new pharmaceutical agents with potential therapeutic benefits.
Used in Materials Science:
4-(2-PHENYLETH-1-YNYL)THIOPHENE-2-CARBALDEHYDE may also find applications in materials science, where its properties could be leveraged to develop new materials with specific characteristics.
Used in the Synthesis of Complex Organic Molecules with Biological Activity:
Due to its potential to be a versatile building block, 4-(2-PHENYLETH-1-YNYL)THIOPHENE-2-CARBALDEHYDE is used in the synthesis of complex organic molecules that may exhibit biological activity. This could lead to the discovery of new bioactive compounds for various applications in life sciences and medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 175203-58-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,2,0 and 3 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 175203-58:
(8*1)+(7*7)+(6*5)+(5*2)+(4*0)+(3*3)+(2*5)+(1*8)=124
124 % 10 = 4
So 175203-58-4 is a valid CAS Registry Number.
InChI:InChI=1/C13H8OS/c14-9-13-8-12(10-15-13)7-6-11-4-2-1-3-5-11/h1-5,8-10H
175203-58-4Relevant academic research and scientific papers
FLUORO-SUBSTITUTED INHIBITORS OF D-AMINO ACID OXIDASE
-
Page/Page column 27-28, (2008/06/13)
This invention provides novel inhibitors of the enzyme D-amino acid oxidase as well as pharmaceutical compositions including the compounds of the invention. The invention also provides methods for the treatment and prevention of neurological disorders, such as neuropsychiatric and neurodegenerative diseases, as well as pain, ataxia and convulsion. The compounds of the invention have the general structure: wherein A is NH or S. Q is a member selected from CR1 and N. X and Y are members independently selected from O, S, CR2, N and NH. R1, R2 and R4 are members independently selected from H and F, provided that at least one member selected from R1, R2 and R4 is F. R6 is a member selected from O?X+ and OH, wherein X+ is a positive ion, which is a member selected from inorganic positive ions and organic positive ions.
